GlassScriptPhysician profile
Jeffrey M Litt
NPI 1417986381
$4,013.50
in general payments reported to CMS, 2019-2025
32 companies · $530 in 2025
The $530 reported for 2025 was more than what 82% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2020: $77.10 · 2021: $42.28 · 2022: $564 · 2023: $799 · 2024: $1,225 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,554.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $657.90 | 2022-2025 | |
| Shield Therapeutics INC | $415.87 | 2023-2025 | Accrufer |
| Abbvie INC. | $363.58 | 2019-2024 | |
| Amgen INC. | $350.20 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $298.97 | 2019-2024 | |
| Astellas Pharma US INC | $292.05 | 2022-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $184.88 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $144.67 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $135.94 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $135.86 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.14 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $113.10 | 2023-2025 | Myfembree |
| Millicent US INC | $112.00 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $89.15 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $72.55 | 2025 | Zurzuvae |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $57.09 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $53.47 | 2022-2024 | Exparel |
| Organon LLC | $47.10 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $45.77 | 2019 | |
| Mallinckrodt Enterprises LLC | $40.25 | 2019 | |
| Avion Pharmaceuticals | $39.55 | 2019-2023 | Balcoltra |
| Allergan, INC. | $38.32 | 2019 | |
| Duchesnay USA Incorporated | $30.11 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.10 | 2019 | |
| Myovant Sciences INC. | $24.13 | 2022 | |
| Optumhealth Care Solutions, LLC | $21.70 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Scynexis, INC. | $21.18 | 2022 | |
| Momentis Surgical INC. | $19.00 | 2022 | |
| Aspira Women'S Health INC | $16.05 | 2019 | |
| Smith+Nephew, INC. | $15.91 | 2024 | Pico, Pico 14 |
| Ethicon US, LLC | $15.54 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Teleflex LLC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Litt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.